Skip to content

Impact of honey on inflammation and metabolic health

Impact of honey on inflammation and metabolic health

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN72027102
Enrollment
50
Registered
2026-01-21
Start date
2023-07-14
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic health in overweight and obese adults Nutritional, Metabolic, Endocrine

Interventions

Potential participants are screened for eligibility conducted via Qualtrics (online survey) using a pre-screen questionnaire regarding inclusion and exclusion criteria. The study is organized as a ra

Sponsors

University of Nebraska–Lincoln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-75 years 2. Body mass index >= (equal or greater than) 27 kg/cm2 3. Participants who read and speak English

Exclusion criteria

Exclusion criteria: 1. Allergic or intolerant to honey 2. Frequent honey consumer (habitual honey consumption of more than 2 tbsp per week in the past 6 months) 3. Oral antibiotic use or antibody ingestion in the past 12 weeks 4. History of GI disease or GI surgery (with the exception of hiatal hernia, GERD/reflux, hemorrhoids, GB surgery, or mild GI symptoms) 5. History of type 1 or type 2 diabetes and/or currently taking any medications for either type 1 or type 2 diabetes 6. History of renal diseases 7. Presence of active cancer (basal and squamous cell skin cancer ok) 8. Received cancer treatment in the past 6 months 9. Consumption of supplemental fiber, probiotics and/or prebiotics in the past 4 weeks (yoghurt is ok) 10. Currently consuming a restrictive diet (keto, Palaeolithic, etc) 11. Plan to have a diet habit and/or exercise habit change during the period of study 12. Changed medication in the past 30 days 13. Female participants who are currently pregnant or planning to become pregnant in the 2 months following consent 14. Female participants who are currently breastfeeding 15. Unwillingness to consent to study and study assessments 16. Requires a LAR 17. Any condition per the PI's discretion that could potentially adversely affect the study outcomes or the participant

Countries

United States of America

Contacts

Public ContactWeiwen Chai
wchai2@unl.edu+1 (402) 472-3716

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 7, 2026